Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 6 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026, Apr 2026, May 2026, Jun 2026, Jul 2026 and Oct 2026.
- Largest single sale: $2.5M (66,610 shares) of Liquidia Corp on Jan 12, 2026. Filing
- Last sale before this period: Oct 13, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Liquidia Corp (LQDA) | Chief Executive Officer, Director | Nov 19, 2020 | Oct 13, 2026 |
| Axsome Therapeutics, Inc. (AXSM) | Director | Nov 19, 2015 | Jun 11, 2026 |
| United Therapeutics Corp (UTHR) | Former Former President and Co-CEO | Aug 18, 2003 | Mar 15, 2016 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 12, 2026, Liquidia Corp: sold 32,744 shares for $933K, under a disclosed plan. 1 filing: 1
- Oct 9, 2026, Liquidia Corp: 28,166 shares vested. 1 filing: 1
- Jul 13, 2026, Liquidia Corp: sold 35,249 shares for $2.5M, under a disclosed plan. 1 filing: 1
- Jul 10, 2026, Liquidia Corp: 28,167 shares vested. 1 filing: 1
- Jun 11, 2026, Axsome Therapeutics, Inc.: sold 286 shares for $71K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.